Desmopressin is a synthetic analogue of arginine vasopressin, commercially available since 1974. Desmopressin is proven effective for the treatment primary nocturnal enuresis and polyuria. It has been considered by several investigators for the treatment of nocturia with positive results and is now an established treatment for this indication. In this review, we assessed the available clinical data on desmopressin in adult urological disease.
BelmakerR.H., BleichA.. The use of desmopressin in adult enuresis.Mil Med.1986; 151: 660–662.
2.
AbramsP., WeissJ., MattiassonA.The efficacy and safety of oral desmopressin in the treatment of nocturia in men.Neurourol Urodyn.2001; 20: 456–457.
3.
AsplundR., SundbergB., BengtssonP.. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.BJU Int.1999; 83: 591–595.
4.
LoseG., van KerrebroeckP., BäckströmT.The efficacy and safety of oral desmopressin in the treatment of nocturia in women.Neurourol Urodyn.2001; 20: 457–458.
5.
HiltonP., HertogsK., StantonS.L.. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.J Neurol Neurosurg Psychiatry.1983; 46: 854–855.
6.
WeissJ.P., BlaivasJ., BliwiseD.The evaluation and treatment of nocturia: a consensus statement.BJU Int.2011; 108(1): 6–21.
7.
BoschJ.L., WeissJ.P.. The prevalence and causes of nocturia.J Urol.2010; 184(2): 440–446.
8.
VilhardtH.. Basic pharmacology of desmopressin a review.Drug Invest.1990; 2(5): 2–8.
9.
InselP.A., TangC-M, HahntowI.Impact of GPCRs in clinical medicine: genetic variants and drug targets.Biochim Biophys Acta.2007; 1768: 994.
10.
SeifS.M., ZeuserT.V., CiarochiF.F., DavisB.B., RobinsonA.F.. DDAVP treatment of central diabetes insipidus - mechanism of prolonged action.J Clin Endocrinol Metab.1978; 46: 381–388.
11.
VilhardtH., BieP.. Antidiuretic effect of perorally administered DDAVP in hydrated humans.Acta Endocrinol (Copenh).1984; 105: 474–476.
12.
RittigS., JensenA.R., JensenK.T., PedersenE.B.. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects.Clin Endocrinol (Oxf).1998; 48(2): 235–241.
13.
RobsonW.L., LeungA.K., NorgaardJ.P.. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.J Urol.2007; 178(1): 24–30.
14.
ThumfartJ., RoehrC.C., KapelariK.Desmopressin associated symptomatic hyponatremic hypervolemia in children.Are there predictive factors? J Urol.2005; 174(1): 294–298.
15.
ChardT.. ‘An Intro.to Radioimmunoassay & Related Tech’.4th ed.Amsterdam: Elsevier; 1990.
16.
TijssenP.. ‘Practice & Theory of Enz. Immunoassays’.Amsterdam: Elsevier; 1985.
17.
SakamotoMl, TanakaI., OkiY., IkedaY., NannoM., YoshimiT.. Atrial natriuretic peptide and vasopressin in human plasma.Peptides.1988; 9(1): 187–191.
18.
BeardwellC.G.. Radioimmunoassay of arginine vasopressin in human plasma.J Clin Endocrinol.1971; 33: 254–260.
SiracusanoS., TornasiP.A., PecorariV., d'AloiaG., StenerS., PappagalloG.. The effect of acute bladder filling on plasmatic antidiuretic hormone production in healthy adult volunteers.Scand J Urol Nephrol.2002; 36(1): 25–27.
21.
TornasiP.A., SiracusanoS., MonniA.M., MelaG., DelitalaG.. Decreased nocturnal urinary antidiuretic hormone excretion in enuresis is increased by imipramine.BJU Int.2001; 88(9): 932–937.
22.
RittigS., SchaumburgH.L., SiggaardC., SchmidtF., DjurhuusJ.C.. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.J Urol.2008; 179(6): 2389–2395.
23.
Van KerrebroekP.. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society.BJU Int.2002; 90(suppl 3): 11–15.
24.
MiddelkoopH.A., Smilde-van den DoelD.A., NevenA.K., KamphuisenH.A., SpringerC.P.. Subjective sleep characteristics of 1,485 males and females aged 50–93: effects of sex and age, and factors related to self-evaluated quality of sleep.J Gerontol A Biol Sci Med Sci.1996; 51(3): M108–15.
25.
JolleysJ.V., DonovanJ.L., NanchahalK., PetersT.J., AbramsP.. Urinary symptoms in the community: how bothersome are they?Br J Urol.1994; 74(5): 551–555.
26.
KobeltG., BorgstromF., MattiassonA.. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia.BJU Int.2003; 91(3): 190–195.
27.
WeissJ.P., BlaivasJ.G.. Nocturnal polyuria versus overactive bladder in nocturia.Urology.2002; 60: 28–32, discussion 32.
AppellR.A., SandP.K.. Nocturia: etiology, diagnosis and treatment.Neurourol Urodyn.2008; 27: 34–39.
30.
AsplundR., SundbergB., BengtssonP.. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study.BJU Int.1999; 83: 591.
31.
CannonA., CarterP.G., McConnellA.A.Desmopressin in the treatment of nocturnal polyuria in the male.BJU Int.1999; 84: 20.
32.
HiltonP., StantonS.L.. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female.Br J Urol.1982; 54: 252.
33.
LoseG., LalosO., FreemanR.M.Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women.Am J Obstet Gynecol.2003; 189: 1106.
34.
LoseG., MattiassonA., WalterS.Clinical experience with desmopressin for long-term treatment of nocturia.J Urol.2004; 172: 1021.
35.
MattiassonA., AbramsP., van KerrebroeckP.Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men.BJU Int.2002; 89: 855.
36.
van KerrebroeckP., RezapourM., CortesseA.Desmopressin in the treatment of nocturia: a doubleblind, placebo-controlled study.Eur Urol.2007; 52: 221.
37.
WeissJ.P., SnyderJ., EllisonW., BelkoffL.. Klein. Fast-dissolving desmopressin (Melt) is well tolerated in nocturia: results of a randomized, placebo-controlled study.J Urol.2010; 183: e589.
ChangS.C., LinA.T., ChenK.K., ChangL.S.. Multifactorial nature of male nocturia.Urology.2006; 67(3): 541–544.
40.
RembrattA., RiisA., NorgaardJ.P.. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.Neurourol Urodyn.2006; 25(2): 105.
41.
YoongH.F., SundaramM.B., AidaZ.. Prevalence of nocturnal polyuria in patients with benign prostatic hyperplasia.Med J Malaysia.2005; 60(3): 294–296.
42.
WangC.J., LinY.N., HuangS.W., ChangC.H.. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study.J Urol.2011; 185(1): 219–223.
43.
EckfordS.D., SwamiK.S., JacksonS.R., AbramsP.H.. Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis.Br J Urol.1994; 74: 733.1;185(1): 219–223.
44.
EckfordS.D., CarterP.G., JacksonS.R.An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia.Br J Urol.1995; 76: 459.
45.
CvetkovicR.S., PloskerG.L.. Desmopressin in adults with nocturia.Drugs.2005; 65: 99.
46.
ZahariouA., KaragiannisG., PapaionnouP.The use of desmopressin in the management of nocturnal enuresis in patients with spinal cord injury.Eura Edicophys.2007; 43: 333.
47.
PatchevV.K., RackéK., AlmedidaO.F.. Adrenalectomy and experimental hypercorticalism modulate the basal, corticotropin-releasing-hormone and arginine-vasopressinstimulated release of hypothalamic beta-endorphin.Neuroendocrinology.1991; 54: 111–117.
48.
el-SherifA.E., SalemM., YahiaH., al-SharkawyW.A., al-SayrafiM.. Treatment of renal colic by desmopressin intranasal spray and diclofenac sodium.J Urol.1995; 153(5): 1395–1398.
49.
ConstantinidesC., KapralosV., ManousakasT., MitropoulosD., AlamanisC., DimopoulosC.. Management of renal colic with intranasal desmopressin spray.Acta Urol Belg.1998; 66(4): 1–3.
50.
KumarS., BeheraN.C., SarkarD., PrasadS., MandaiA.K., SinghS.K.. A comparative assessment of the clinical efficacy of intranasal desmopressin spray and diclofenac in the treatment of renal colic.Urol Res.2011; 39(5): 397–400.
51.
GoldbergH., BanielJ., ManoR., GillonG., KedarD., YossepowitchO.. Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion.BJU Int.2014; 114(5): 727–732.
52.
National Institute for Health and Clinical Excellence.NICE clinical guideline 97. Lower urinary tract symptoms: the management of lower urinary tract symptoms in men [Internet].London: National Institute for Health and Clinical Excellence; c2010 [cited 2012 Jun 4]. Available from: https://www.nice.org.uk/guidance/cg97.
